SYBX Synlogic

Synlogic Inc, formerly known as Mirna Therapeutics Inc is a clinical-stage biopharmaceutical company which is engaged in developing a pipeline of microRNA (ribonucleic acid)-based oncology therapeutics.

As of 10/04/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/01/2015
Outstanding shares:  70,229,592
Average volume:  84,380
Market cap:   $66,718,112
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Valuation   (See tab for details)
PE ratio:   -1.13
PB ratio:   0.53
PS ratio:   61.66
Return on equity:   -46.33%
Net income %:   -5,664.23%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy